Anti-COPA1/ COL25A1/ AMY monoclonal antibody
Anti-COPA1/ COL25A1/ AMY antibody for FACS & in-vivo assay
Go to COL25A1/COL25A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0324-Ab-1/ GM-Tg-hg-MP0324-Ab-2 | Anti-Human COL25A1 monoclonal antibody | Human |
GM-Tg-rg-MP0324-Ab-1/ GM-Tg-rg-MP0324-Ab-2 | Anti-Rat COL25A1 monoclonal antibody | Rat |
GM-Tg-mg-MP0324-Ab-1/ GM-Tg-mg-MP0324-Ab-2 | Anti-Mouse COL25A1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0324-Ab-1/ GM-Tg-cynog-MP0324-Ab-2 | Anti-Cynomolgus/ Rhesus macaque COL25A1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0324-Ab-1/ GM-Tg-felg-MP0324-Ab-2 | Anti-Feline COL25A1 monoclonal antibody | Feline |
GM-Tg-cang-MP0324-Ab-1/ GM-Tg-cang-MP0324-Ab-2 | Anti-Canine COL25A1 monoclonal antibody | Canine |
GM-Tg-bovg-MP0324-Ab-1/ GM-Tg-bovg-MP0324-Ab-2 | Anti-Bovine COL25A1 monoclonal antibody | Bovine |
GM-Tg-equg-MP0324-Ab-1/ GM-Tg-equg-MP0324-Ab-2 | Anti-Equine COL25A1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0324-Ab-1/ GM-Tg-hg-MP0324-Ab-2; GM-Tg-rg-MP0324-Ab-1/ GM-Tg-rg-MP0324-Ab-2; GM-Tg-mg-MP0324-Ab-1/ GM-Tg-mg-MP0324-Ab-2; GM-Tg-cynog-MP0324-Ab-1/ GM-Tg-cynog-MP0324-Ab-2; GM-Tg-felg-MP0324-Ab-1/ GM-Tg-felg-MP0324-Ab-2; GM-Tg-cang-MP0324-Ab-1/ GM-Tg-cang-MP0324-Ab-2; GM-Tg-bovg-MP0324-Ab-1/ GM-Tg-bovg-MP0324-Ab-2; GM-Tg-equg-MP0324-Ab-1/ GM-Tg-equg-MP0324-Ab-2 |
Products Name | Anti-COL25A1 monoclonal antibody |
Format | mab |
Target Name | COL25A1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-COL25A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species COPA1/ COL25A1/ AMY VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP0324 |
Target Name | COL25A1 |
Gene ID | 84570,77018,687064,697122,102152687,105260507,615661,100072894 |
Gene Symbol and Synonyms | 2700062B08Rik,AMY,CFEOM5,CLAC,CLAC-P,CLACP,COL25A1 |
Uniprot Accession | Q9BXS0 |
Uniprot Entry Name | COPA1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000188517 |
Target Classification | N/A |
The target: COL25A1, gene name: COL25A1, also named as AMY, CFEOM5, CLAC, CLAC-P, CLACP. This gene encodes a brain-specific membrane associated collagen. A product of proteolytic processing of the encoded protein, CLAC (collagenous Alzheimer amyloid plaque component), binds to amyloid beta-peptides found in Alzheimer amyloid plaques but CLAC inhibits rather than facilitates amyloid fibril elongation (PMID: 16300410). A study of over-expression of this collagen in mice, however, found changes in pathology and behavior suggesting that the encoded protein may promote amyloid plaque formation (PMID: 19548013). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.